|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$460,324
|
$460,324
|
Barchi, Joseph
|
CCR (NCI)
|
|
A novel pathway to clear cells of misfolded proteins
|
ZIA BC 011628
|
$332,539
|
$83,135
|
Walters, Kylie
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$104,749
|
$104,749
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,007,151
|
$50,358
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$76,885
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$361,814
|
$253,270
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$372,283
|
$372,283
|
Apolo, Andrea
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$15,841
|
$7,920
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,919,499
|
$191,950
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$806,358
|
$161,272
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$10,042
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$504,068
|
$50,407
|
Garfield, Susan
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$294,411
|
$14,721
|
Jones, Jennifer
|
CCR (NCI)
|
|
Characterization of the interaction between inflammation and cancer progression
|
ZIA BC 010892
|
$283,350
|
$141,675
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$348,030
|
$174,015
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$773,659
|
$464,195
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,773
|
$386,830
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$113,744
|
$28,436
|
Bates, Susan
|
CCR (NCI)
|
|
Comparison of molecular factors to drug activities.
|
ZIC BC 011509
|
$83,461
|
$8,346
|
Reinhold, William
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,113,615
|
$111,362
|
Young, Howard
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$69,833
|
$69,833
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$639,870
|
$127,974
|
Meier, Jordan
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$78,595
|
$7,860
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$189,189
|
$56,757
|
Beutler, John
|
CCR (NCI)
|
|
DNA Sequencing and FACS Core Facilities
|
ZIC BC 010948
|
$1,458,626
|
$72,931
|
Robbins, Paul
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$139,666
|
$139,666
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,735,022
|
$173,502
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,104,439
|
$110,444
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$502,025
|
$100,405
|
Yang, James
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$290,767
|
$5,815
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$460,284
|
$460,284
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Genomics and Bioinformatics Group web site development and maintenance.
|
ZIC BC 011475
|
$166,923
|
$33,385
|
Reinhold, William
|
CCR (NCI)
|
|
Growth/Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$629,820
|
$566,838
|
Perantoni, Alan
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$34,916
|
$34,916
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,032,939
|
$51,647
|
Kleiner, David
|
CCR (NCI)
|
|
Human Papillomavirus, HIV, and Penile Cancer Precursors in the Rakai Circumcisio
|
ZIA CP010212 - 10401
|
$460
|
$460
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$306,856
|
$61,371
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$104,794
|
$104,794
|
Bottaro, Donald
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$539,792
|
$26,990
|
Khan, Javed
|
CCR (NCI)
|
|
Immunophysiological Mechanisms in the Biological Therapy of Cancer
|
ZIA BC 009262
|
$566,700
|
$283,350
|
Wiltrout, Robert
|
CCR (NCI)
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$84,603
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,117,366
|
$558,683
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Investigation of Epigentic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$34,916
|
$34,916
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$170,616
|
$34,123
|
Bates, Susan
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$872,302
|
$43,615
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,389,288
|
$658,393
|
Gulley, James
|
CCR (NCI)
|
|
Metabolic Mechanisms for Programmed Cell Death
|
ZIA BC 010743
|
$233,700
|
$93,480
|
Phang, James
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$114,102
|
$114,102
|
Merino, Maria
|
CCR (NCI)
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$412,674
|
$206,337
|
Fojo, Antonio
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $15,915,650
|